Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 6:19 PM
What would change this read
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
TL;DR
Seed (YC)Exonic – AI for precision gene therapy AI-driven precision gene therapy and open discovery tournaments.
Raised $500K across 1 funding round. Latest: $500K Seed (Sep 2025). Investors: Y Combinator. (High).
Funding
Raised $500K across 1 funding round. Latest: $500K Seed (Sep 2025). Investors: Y Combinator. (High).
Product / news
2 product/news‑styled row(s); headline risk without filings (High).
Verified facts
Fall 2025 batch; unsupervised biological AI for safer gene-therapy design via crowdsourced discovery.
Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.
No open roles indexed yet.
The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.
Source types found
Strongest / recent news-style rows
Customers · Thu, Jul 2, 03:07 PM · confidence 70%high quality
Pricing · Thu, Jul 2, 03:07 PM · confidence 70%high quality
About page · Thu, Jul 2, 03:07 PM · confidence 70%high quality
Newest first · 30 event(s)
Source: Customers
AI for precision gene therapy.
Source: Pricing
AI for precision gene therapy.
Source: Blog
AI for precision gene therapy.
Source: Careers page
AI for precision gene therapy.
Source: About page
AI for precision gene therapy.
Source: Homepage
AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: official_site
Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Source: Blog / news
AI for precision gene therapy.
Source: Blog / news
AI for precision gene therapy.
Source: Careers
AI for precision gene therapy.
Source: About / company
AI for precision gene therapy.
Open tournament product surface on official domain.
Fall 2025 batch; unsupervised biological AI for safer gene-therapy design via crowdsourced discovery.
YC launch on crowdsourced drug discovery and enhancer results.
16 row(s)
The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.
AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Exonic – AI for precision gene therapy Exonic – AI for precision gene therapy AI for precision gene therapy.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗8 row(s)
Third-party press coverage. Independent reporting corroborates company claims; repeated coverage across outlets is a momentum signal.
AI for precision gene therapy.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗AI for precision gene therapy.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗AI for precision gene therapy.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗AI for precision gene therapy.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Open tournament product surface on official domain.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗YC launch on crowdsourced drug discovery and enhancer results.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗1 row(s)
Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.
Fall 2025 batch; unsupervised biological AI for safer gene-therapy design via crowdsourced discovery.
Why it matters: Funding signal — Seed per this source; verify against the linked original before relying on it.
Open source ↗2 row(s)
Open roles and careers pages. Active hiring implies runway to spend and shows where the company is investing (engineering vs GTM vs ops).
AI for precision gene therapy.
Why it matters: Hiring signal — open roles imply runway to spend and show where the company is investing.
Open source ↗AI for precision gene therapy.
Why it matters: Hiring signal — open roles imply runway to spend and show where the company is investing.
Open source ↗3 row(s)
Company blog and newsletters. Shipping cadence and technical depth of posts hint at product velocity and team quality.
AI for precision gene therapy.
Why it matters: Company publishing — post cadence and depth hint at product velocity.
Open source ↗AI for precision gene therapy.
Why it matters: Company publishing — post cadence and depth hint at product velocity.
Open source ↗AI for precision gene therapy.
Why it matters: Company publishing — post cadence and depth hint at product velocity.
Open source ↗Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.